Join the Oncology Voice Network. Join for Free
The Authority Company | Breaking Silos in Oncology
oncologyinnovation cancercare biotechleadership pharmacommunity oncologyresearch collaborationinscience lifesciences patientimpact healthinnovation oncologyvoicenetwork

The Authority Company | Breaking Silos in Oncology


Share This Article


Summary

In this episode of The Authority Company Podcast, host Joe Pardavila sits down with Dr. Ramin Farhood and Dr. Kirk Shepard, co-authors of Voices of Oncology and co-founders of the Medical Affairs Professional Society (MAPS). Together, they share how breaking down silos, fostering collaboration, and elevating the patient voice are reshaping the future of oncology drug development. Farhood and Shepard reflect on their decade-long partnership in oncology, the lessons learned from working across functions, and why they believe true progress depends on bringing every perspective to the table—from scientists and regulators to patients and advocates. They discuss the “moonshot” mindset, the surprising insights from more than 30 contributors to their book, and how advances in AI and real-time FDA review processes are accelerating the path from research to treatment. This conversation highlights the optimism, challenges, and collaborative breakthroughs driving innovation in cancer care—and why building a global community of experts is essential to finding cures.

Podcast
Watch on YouTube
Joe Pardavila sits down with Dr. Ramin Farhood and Dr. Kirk Shepard to discuss breaking down silos, fostering collaboration, and elevating the patient voice are reshaping the future of oncology drug development.

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Press Release
Announcing the Launch of Voices of Oncology: A Landmark Collaboration with Forbes
OVN Avatar OVN Staff

Announcing the Launch of Voices of Oncology: A Landmark Collaboration with Forbes

Press Release
Visionaries Behind Oncology Voice Network: Dr. Ramin Farhood & Dr. Kirk Shepard
OVN Avatar OVN Staff

Visionaries Behind Oncology Voice Network: Dr. Ramin Farhood & Dr. Kirk Shepard

Press Release
Introducing OncologyVoiceNetwork.com
OVN Avatar OVN Staff

Introducing OncologyVoiceNetwork.com

Article
AI-powered real-world evidence: Strategically enhancing value and access
Partner Avatar Envision Pharma Group

AI-powered real-world evidence: Strategically enhancing value and access

Article
Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions
OVN Avatar Kushal T. Kadakia, MSc, Malke Asaad, MD, Erica Adlakha, MS, Michael J. Overman, MD, Cristina M. Checka, MD, and Anaeze C. Offodile II, MD, MPH

Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions

Article
Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years
OVN Avatar Emmanuelle Jacqueta, Ghania Kerouani-Lafayeb, Francoise Grudeb, Sergio Goncalvesb, Annie Lorenced, Florence Turcryb, Liora Brunelb, Laetitia Belgodereb, Adrien Monardc, Gaëlle Guyaderb, Lotfi Boudalib, Nicolas Albin

Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years

Explore OVN